首页> 外文期刊>Nature >Structure and control of the actin regulatory WAVE complex
【24h】

Structure and control of the actin regulatory WAVE complex

机译:肌动蛋白调节性WAVE复合物的结构和控制

获取原文
获取原文并翻译 | 示例
       

摘要

Members of the Wiskott-Aldrich syndrome protein (WASP) family control cytoskeletal dynamics by promoting actin filament nucleation with the Arp2/3 complex. The WASP relative WAVE regulates lamellipodia formation within a 400-kilodalton, hetero-pentameric WAVE regulatory complex (WRC). The WRC is inactive towards the Arp2/3 complex, but can be stimulated by the Rac GTPase, kinases and phosphatidylinositols. Here we report the 2.3-angstrom crystal structure of the WRC and complementary mechanistic analyses. The structure shows that the activity-bearing VCA motif of WAVE is sequestered by a combination of intramolecular and intermolecular contacts within the WRC. Rac and kinases appear to destabilize a WRC element that is necessary for VCA sequestration, suggesting the way in which these signals stimulate WRC activity towards the Arp2/3 complex. The spatial proximity of the Rac binding site and the large basic surface of the WRC suggests how the GTPase and phospholipids could cooperatively recruit the complex to membranes.
机译:Wiskott-Aldrich综合征蛋白(WASP)家族的成员通过促进肌动蛋白丝与Arp2 / 3复合物的成核来控制细胞骨架动力学。 WASP相对WAVE调节400千达尔顿,杂五聚体WAVE调节复合物(WRC)中的片状脂蛋白形成。 WRC对Arp2 / 3复合物无活性,但可被Rac GTPase,激酶和磷脂酰肌醇刺激。在这里,我们报告WRC的2.3埃晶体结构和互补的机理分析。该结构表明,WAVE的带有活性的VCA基序被WRC内分子内和分子间接触的结合所隔离。 Rac和激酶似乎破坏了VCA螯合所必需的WRC元素的稳定性,表明这些信号刺激WRC对Arp2 / 3复合物的活性的方式。 Rac结合位点和WRC的大基本表面在空间上的接近性表明,GTPase和磷脂如何协同将复合物募集到膜上。

著录项

  • 来源
    《Nature》 |2010年第7323期|p.533-538|共6页
  • 作者单位

    Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, Texas 75390, USA;

    rnDepartment of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA;

    rnDepartment of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, Texas 75390, USA;

    rnDivision of Oncology Research, Schulze Center for Novel Therapeutics, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA;

    Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, Texas 75390, USA;

    rnDepartment of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, Texas 75390, USA;

    rnDepartment of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, Texas 75390, USA;

    rnDivision of Oncology Research, Schulze Center for Novel Therapeutics, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA;

    Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA;

    rnDepartment of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, Texas 75390, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:55:20

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号